Oesophageal cancer treatment: Studies, strategies and facts

Annals of Oncology

Volumn 9, Issue 9, 1998, Pages 951-962

  Wobst, A ^a   Audisio, R A ^a   Colleoni, M ^a   Geraghty, J G ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Multimodality treatment; Oesophageal cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLIC ACID; FOLINIC ACID; GEMCITABINE; HYDROXYUREA; MITOMYCIN; NAVELBINE; PACLITAXEL; TOPOTECAN; VINBLASTINE; VINDESINE;

BARRETT ESOPHAGUS; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW;

EID: 0031766323     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008273110272     Document Type: Review

References (103)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
2. Cook P. The epidemiology and pathology of cancer of the esophagus. Philadelphia, PA: WB Saunders 1980.
3. Munoz N, Castellsague' X. Epidemiology of oesophageal cancer. Eur J Gastroenterol Hepatol 1994; 6: 649-55.
4. National Cancer Institute. Cancer statistics review 1973-1987. Cancer 1990; HHS, PHS, NIH Public.
5. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Int J Cancer 1993; 55: 891-903.
6. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: An update. JAMA 1993; 270: 1320 (Letter).
7. Blot WJ, Devesa SS, Kneller RW et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
8. Hoelscher AH, Bollschweiler E, Schneider PM et al. Prognosis of early esophageal cancer. Cancer 1995; 76 (2): 178-86.
9. Lieberman MD, Shriver CD, Bleckner S et al. Carcinoma of the esophagus. J Thorac Cardiovasc Surg 1995; 109: 130-9.
10. Klimstra DS. Pathologic prognostic factors in esophageal carcinoma. Semin Oncol 1994; 21 (4): 425-30.
11. Hermanek P, Sobin LM. UICC, TNM classification of malignant tumours. Berlin: Springer Verlag 1987.
12. Esophagus. In American Joint Committee on Cancer (ed): Manual for the Staging of Cancer. 4th ed. Philadelphia: JB Lippincott 1992; 57-9.
13. Whittington R, Coia LR, Haller DG et al. Adenocarcinoma of the esophagus and esophago-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment. Int J Radiat Oncol Biol Phys 1990; 19: 593-603.
14. Yamada A, Kobayashi S. Diagnosis and treatment of early esophageal carcinoma. Zentralblatt Chirurg 1985; 110: 1399-413.
15. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma. Cancer Causes Control 1996; 7: 322-7.
16. Provenzali D, Kemp A, Arora S et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994; 89 (5): 670-80.
17. Menke-Plumymers MBE, Schoute NW, Mulder AH et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992; 33: 1454-8.
18. Stretz JM, Ellis FHE, Gibb SP et al. Adenocarcinoma in Barrett's esophagus. Ann Surg 1990; 213 (2): 122-5.
19. Heitmiller RF, Redmond M, Hamilton S. Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 224 (1): 66-71.
20. Edwards MJ, Gable DRG, Lentsch AB et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 223 (5): 585-91.
21. Mc Caughan JW, Ellison EC, Guy JT et al. Photodynamic therapy for esophageal malignancy: A prospective twelve-year study. Ann Thorac Surg 1996; 62: 1005-10.
22. Overholt BF, Panjehopour M. Photodynamic therapy for Barrett's esophagus: Clinical update. Am J Gastroenterol 1996; 91 (9): 1719-23.
23. Barr H, Shepherd NA, Dix A et al. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348 (9027): 584-5.
24. Ferrando J, Reig G. Barrett esophagus as precancerous lesion. Rev Esp Enferm Dig 1991; 80 (2): 83-6.
25. Spechler SJ, Zeroogian JM, Antonioli DA et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344 (8936): 1533-6.
26. Kahrilas PJ. Gastresophageal reflux disease. JAMA 1996; 276 (12): 983-8.
27. Streitz JM Jr. Barrett's esophagus and esophageal cancer. Chest Surg Clin N Am 1994; 4 (2): 227-40.
28. Atkinson M, Iftikhar SY, James PD et al. The early diagnosis of oesophageal adenocarcinoma by endoscopie screening. Eur J Cancer Prev 1992; 1 (4): 327-30.
29. Dent J, Bremner CG, Collen MJ et al. Barrett's oesophagus: Working party reports of the ninth world congresses of gastroenterology. Melbourne, Australia: Blackwell Scientific Publications 1990; 17-26.
30. Clark GW, Ireland AP, DeMeester TR. Dysplasia in Barrett's esophagus: Diagnosis, surveillance and treatment. Dig Dis Sci 1996; 14 (4): 213-7.
31. Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67: 381-90.
32. Mueller JM, Erasmi H, Stelzner M et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
33. Roder JD, Busch R, Stein HJ et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81: 410-3.
34. Siewert JR, Fink U, Beckurts KTE et al. Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 1994; 5: 1-7.
35. Lerut T. Oesophageal carcinoma past and present studies. Eur J Surg Oncol 1996; 22: 317-25.
36. Hoelschcr AH, Bollschweiler E, Bumm R et al. Prognostic factors of resected adenocarcinoma of the esophagus. Surgery 1995; 118: 845-55.
37. Akiyama H, Masahiko T, Udagawa H et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-73.
38. Isono K, Onada S, Ishikawa T et al. Studies on the causes of deaths from esophageal carcinoma. Cancer 1982; 49: 2173-9.
39. Mandard AM, Chasle J, Marnay J et al. Autopsy findings in 111 cases of esophageal cancer. Cancer 1981; 48: 329-35.
40. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983; 85: 59-71.
41. Hagen JA, Peters JH, DeMeeser TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106: 583-90.
42. Kato H, Tachimori Y, Watanabe H et al. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol 1991; 48: 106-11.
43. Siewert JR, Roder JD. Lymphadenectomy in esophageal cancer surgery. Dis Esophagus 1992; 5: (2): 91-6.
44. Isono K, Sato H et al. Result of a nationwide study on the three field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-6.
45. Kato H, Watanabe H, Tachimori Y et al. Evaluation of neck lymph node dissection for throacic carcinoma. Ann Thorac Surg 1991; 51: 931-5.
46. Skinner DB. Cervical lymph node dissection for thoracic esophageal cancer. Ann Thorac Surg 1991; 51: 884-5.
47. Udagawa H, Tsurumaru M, Ono Yet et al. Lymph node dissection and TNM classification. In Proceedings of the sixth Congress of the Japanese Section of the ISDE. Kurume 1990; 26.
48. Isono K, Ochaiai T, Koide Y. More or less surgery for esophageal cancer - indications for extended three field lymphadenectomy for esophageal cancer. Dis Esophagus 1994; 7: 147-50.
49. Skinner DB, Ferguson MK, Soriano A et al. Selection of operation for esophageal cancer based on staging. Ann Surg 1986; 204: 391-401.
50. Baba M, Aikou T, Natsgoue S et al. Lymph node and perinodal tissue tumor involvement in patients with esophagectomy and three field lymphadenectomy for carcinoma of the esophagus. J Surg Oncol 1997; 64: 12-6.
51. Herskovic A, Martz K, Muhyi AS et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
52. Zieren HU, Mueller JM, Jacobi CA et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study. World J Surg 1995; 19: 444-9.
53. Fok M, Sham JST, Choy D et al. Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study. Surgery 1993; 113: 138-47.
54. Teniere P, Hay JM, Fingerhut A et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173: 123-30.
55. Arnott SJ, Duncan W, Kerr GR et al. Low-dose preoperative radiotherapy for carcinoma of the oesophagus: Results of a randomized clinical trial. Radiother Oncol 1992; 24: 108-13.
56. Mei W, Xian-Zhi G, Weibo Y et al. Randomized controlled clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients. Int J Radiat Oncol Biol Phys 1989; 16: 325-7.
57. Iizuka T, Ide H, Kakegawa T et al. Preoperative radioactive therapy for esophageal carcinoma. Chest 1993; 5: 1054-8.
58. Launois B, Delarue D, Campion JP et al. Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 153: 690-2.
59. EORTC. Preoperative radiotherapy for carcinoma of the esophagus: Results of a prospective multicentric study. In De Meester TR, Skinner DB (eds): Esophageal Disorders: Pathophysiology and Therapy. New York: Raven Press 1985; 367-71.
60. Nygaard K, Hagen S, Hansen HS et al. Pre-operative radiotherapy prolongs survival in operable esophgageal carcinoma: A randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second scandinavian trial in esophgageal cancer. World J Surg 1992; 16: 1104-10.
61. Maipang T, Vasinanukorn P, Petpichetchian C et al. Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994; 56: 191-7.
62. Schlag P. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992; 127: 1446-50.
63. Roth JA, Pass H, Flanagan MM et al. Randomized clincial trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96: 242-8.
64. Wright CD, Mathisen DJ, Wain JC et al. Evolution of treatment strategies for adenocarcinom of the esophagus and gastroesophageal junction. Ann Thorac Surg 1994; 58: 1574-9.
65. Bosset JF, Gignoux M, Triboulet JP et al. Randomized phase III clinical trial comparing surgery alone versus pre-operative combined radiochemotherapy in stage I-II epidermoid cancer of the thoracic oesophagus: Preliminary analysis. A study of the FFCD (no 8805) and EORTC (no. 40881). Proc Am Soc Clin Oncol 1994; 13: 197 (Abstr).
66. Le Prise E, Etienne P, Meunier B et al. A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
67. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing transhiatal esophagectomy to preoperative chemoradiation followed by esophagectomy in locoregional esophageal carcinoma. Proc Am Soc Clin Oncol 1995; 14: 119 (Abstr).
68. Walsh TN, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
69. Bates BA, Detterbeck FC, Bernard SA et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-63.
70. Burmeister BH, Rad FF, Denham JW et al. Combined modality therapy for esophageal carcinoma: Prelimimary results from a large australasian multicenter study. Int J Radiat Oncol Biol Phys 1995; 32 (4): 997-1006.
71. Carey RW, Hilgenbcrg AD, Wilkins EW Jr et al. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 1993; 11 (2): 99-105.
72. Ferguson MK, Laurie BR, Hoffman PC et al. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg 1995; 2 (2): 101-6.
73. Forastiere AA, Orringer MB, Perez-Tamayo C et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118-23.
74. Hoff SJ, Stewart JR, Sawyers JL et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993; 56: 282-7.
75. Japanese esophageal oncology group. A comparison of chemotherapy and radiotherapy as adjuvant treatment of surgery for esophageal carcinoma. Chest 1993; 104: 203-7.
76. Kitamura K, Kuwano H, Watanabe M et al. Prospective randomized study of hyperthermia comined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol 1995; 60: 55-8.
77. Millikan KW, Silverstein J, Hart V et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995; 130: 617-24.
78. Naunheim KS, Petruska PJ, Roy TS et al. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995; 59: 1085-91.
79. Naunheim KS, Petruska PJ, Roy TS et al. Preoperative chemotherapy and radiotherapy or esophageal carcinoma. J Thorac Cardiovasc Surg 1992; 103: 887-95.
80. Poplin EA, Jacobson J, Herskovic A et al. Evaluation of multimodality treatment of locoregional esophageal carcinoma by southwest oncology group 9060. Cancer 1996; 78: 851-6.
81. Poplin EA, Khanuja PS, Kraut MJ et al. Chemoradiotherapy of esophageal carcinoma. Cancer 1994; 74: 1217-24.
82. Stahl M, Wilke H, Fink U et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-37.
83. Steward JR, Hoff SJ, Johnson DH et al. Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993; 218 (4): 571-8.
84. Vogel SB, Mendenhall WM, Sombeck MD et al. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221 (6): 685-95.
85. Wolfe WG, Vaughn AL, Seigler HF et al. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993; 105: 749-56.
86. Ganem G, Cubray B, Raoul Yet al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol 1997; 15: 701-11.
87. de Pree C, Aapro MS, Spiliopoulos A et al. Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol 1995; 6: 551-7.
88. Forastiere AA, Heitmiller RF, Lee DJ et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 1997; 3: 144-52.
89. Pouliquen X, Levard H, Hay JM et al. 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. Ann Surg 1996; 223 (2): 127-33.
90. Minsky BD, Neuberg D, Kelsen D et al. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus - a preliminary analysis of the phase II Intergroup trial 0122. J Clin Oncl 1996; 14: 149-55.
91. Sur RK, Singh DP, Sharma SC. Radiation therapy of esophageal cancer: Role of high-dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992; 22: 1943-6.
92. Jager J, Langendijk H, Pannebadder M et al. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol 1995; 37: 237-40.
93. Sischy B, Ryan L, Haller D et al. Interim report of the EST 1282 phase III protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus. Proc Am Soc Clin Oncol 1990; 9: 105 (abstr).
94. Desai PB, Deshpande RK, Patil PK et al. Radical lymphadenectomy in esophageal cancer: Does it improve survival? Dis Esoph 1992; 5: 99-104.
95. Perachiacchia A, Bardini R, Castoro C et al. Lymphadenctomie dans le traitment du cencer de l'oesophage intrathoracique. A propos de l'etude de 240 cas. Ann Chir 1990; 44: 9-17.
96. Bosch A, Frias Z, Caldwell WL et al. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol 1997; 18: 103-5.
97. Chan KW, Chan EY, Chan CW. Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology 1996; 18: 400-5.
98. Sobin LH, Wittekind Ch. TNM-Classification of malignant tumours, 5th ed. John Wiley & Sons Inc., New-York 1997.
99. Clark GW, Roy MK, Corcoran BA et al. Carcinoma of the eosophagus: The time for a multidisciplinary approach? Surg Oncol (1996); 5 (4): 149-64.
100. Kelsen DP, Ginsberg R, Qian C et al. Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer: A preliminary report of intergroup study 113 (RTOG 89-110). Proc Am Soc Clin Oncol 1997; 16: 276a.
101. Wilke HJ, Fink U. Multimodal therapy for adenocarcinoma of the esophagus and esophagogastric junction. N Engl J Med 1996; 335: 509-11.
102. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
103. Urba S, Orringer M, Turrisi A et al. A randomized trial comparing surgery (S) to preoperative concomitant chemoradiation plus surgery in patients (pts) with resectable esophageal cancer (CA): Updated analysis. Proc Am Soc Clin Oncol 1997; 337: 277a.